Regeneron Pharmaceuticals, Inc. (REGN)

NASDAQ: REGN · Real-Time Price · USD

718.36

-4.44 (-0.61%)

At close: Dec 5, 2025, 4:00 PM EST

721.00

+2.64 (0.37%)

After-hours: Dec 5, 2025, 7:45 PM EST

Regeneron Pharmaceuticals Market Cap

Regeneron Pharmaceuticals has a market cap or net worth of $73.70 billion as of December 5, 2025. Its market cap has decreased by -11.98% in one year.

Market Cap

73.70B

Enterprise Value

57.68B

1-Year Change

-11.98%

Ranking

#206

Market Cap Chart

Since December 1, 1998, Regeneron Pharmaceuticals's market cap has increased from $252.00M to $73.70B, an increase of 29,147.36%. That is a compound annual growth rate of 23.38%.

Market Cap History

Date	Market Cap	% Change
Dec 4, 2025	75.97B	-2.95%
Dec 31, 2024	78.28B	-18.19%
Dec 29, 2023	95.69B	21.78%
Dec 30, 2022	78.57B	15.69%
Dec 31, 2021	67.92B	31.74%
Dec 31, 2020	51.55B	25.04%
Dec 31, 2019	41.23B	1.98%
Dec 31, 2018	40.43B	0.08%
Dec 29, 2017	40.39B	4.33%
Dec 30, 2016	38.72B	-31.47%
Dec 31, 2015	56.49B	35.45%
Dec 31, 2014	41.71B	52.42%
Dec 31, 2013	27.36B	65.66%
Dec 31, 2012	16.52B	221.91%
Dec 30, 2011	5.13B	89.94%
Dec 31, 2010	2.70B	38.80%
Dec 31, 2009	1.95B	33.11%
Dec 31, 2008	1.46B	-8.46%
Dec 31, 2007	1.60B	38.55%
Dec 29, 2006	1.15B	29.12%
Dec 30, 2005	893.00M	73.94%
Dec 31, 2004	513.40M	-36.89%
Dec 31, 2003	813.50M	-0.20%
Dec 31, 2002	815.10M	-33.81%
Dec 31, 2001	1.23B	-5.01%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	908.36B
Johnson & Johnson	487.83B
AbbVie	404.22B
UnitedHealth Group	302.09B
AstraZeneca	279.81B
Novartis AG	255.73B
Merck & Co.	250.41B
Abbott Laboratories	218.05B

Market Cap Rankings